Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2026-02-10 00:00:00 ET · period of report 2026-02-06 · accession 0001610717-26-000048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-10 | 2026-02-06 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.54 | +24.0K | 256.5K | +10% | +$13.0K |
| D | 2026-02-10 | 2026-02-06 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.00 | -24.0K | 144.5K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-06 | M | A | 24,010 | $0.54 | 256,479 | D | — | — | (F1) Includes 168,763 restricted stock units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-02-06 | M | D | 24,010 | $0.00 | 144,493 | D | $0.54 · 2022-03-01 to 2028-02-11 | 24,010 Common Stock |